Country: New Zealand
Language: English
Source: Ministry for Primary Industries
meloxicam
Chanelle Pharmaceuticals Manufacturing Limited
meloxicam
meloxicam 5 g/litre
Analgesic
ACVM Registered
2015-11-26
TEXT LABEL: RHEUMOCAM 5 mg/mL SOLUTION FOR INJECTION Immediate Container Label: Main Panel Text appearing above the Header and below the Footer lines is not included in the label 16 November 2023 Version 4 Page 1 of 7 KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY RESTRICTED VETERINARY MEDICINE RHEUMOCAM 5 MG/ML SOLUTION FOR INJECTION Active Constituent: Meloxicam 5 mg/mL A non-steroidal anti-inflammatory for use in dogs and cats. 10 mL [20 mL, 100 mL] TEXT LABEL: RHEUMOCAM 5 mg/mL SOLUTION FOR INJECTION Immediate Container Label: Ancillary Panel Text appearing above the Header and below the Footer lines is not included in the label 16 November 2023 Version 4 Page 2 of 7 READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. DIRECTIONS FOR USE DISCARD UNUSED PRODUCT 28 DAYS AFTER FIRST BROACHING THE VIAL. Do not use in pregnant or lactating animals, or those less than 6 weeks of age. DOSAGE AND ADMINISTRATION: DOGS: 0.4 mL/10 kg (0.2 mg meloxicam/ kg bodyweight) single IV or SC. CATS: 0.3 mL/5 kg (0.3 mg meloxicam/ kg bodyweight) single SC. STORAGE: Store below 25°C. Registered to Chanelle Pharmaceuticals Manufacturing Limited, Ireland Distributed By: Ethical Agents Veterinary Marketing Ltd Phone: 0800 800 624 www.ethicalagents.co.nz ACVM Approval No. A11264 Batch No.: Expiry: TEXT LABEL: RHEUMOCAM 5 mg/mL SOLUTION FOR INJECTION Carton: Main Panel Text appearing above the Header and below the Footer lines is not included in the label 16 November 2023 Version 4 Page 3 of 7 KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY RESTRICTED VETERINARY MEDICINE RHEUMOCAM 5 MG/ML SOLUTION FOR INJECTION Active Constituent: Meloxicam 5 mg/mL A non-steroidal anti-inflammatory for use in dogs and cats. 10 mL [20 mL, 100 mL] TEXT LABEL: RHEUMOCAM 5 mg/mL SOLUTION FOR INJECTION Carton: Ancillary Panels Text appearing above the Header and below the Footer lines is not included in the label 16 November 2023 Version 4 Page 4 of 7 For the alleviation of inflammation and pain in both acute and chronic musculoskeletal dis Read the complete document